You’ve heard of Creative Commons; here’s Cancer Commons.
Modern medicine believes that cancer isn’t one disease, but “hundreds or thousands of rare diseases”, which makes it nigh on impossible for a physician to prescribe exactly the right treatment for each patient. And traditional drug therapies are tested on randomized heterogeneous study groups, which means they have a roughly 70% failure rate as what’s good for the group doesn’t always help the individual. Cancer Commons aims to pool the knowledge of 30,000 cancer specialists and help doctors design individualized treatments by drawing on a huge body of research and experience. They’re concentrating on melanoma at the moment but plan to roll it out to other types of cancer in future.
Read more here.